ADMA (Asymmetrical Dimethylarginine) ELISA Kit | G-EC-00019

ADMA (Asymmetrical Dimethylarginine) ELISA Kit | G-EC-00019 | Gentaur Elisa Kits

Target Species: Universal

Type: Competitive

Assay Time: 2.5h

Detection Type: Colormetric

Sensitivity: 9.38ng/mL

Detection Range: 15.63~1000ng/mL

UniProt ID:

Target Name: ADMA

Target Synonym: N, N-Dimethylarginine, NG-Dimethylarginine dihydrochloride, 2-Amino-5-[ (amino-dimethylaminomethylene) amino]pentanoic acid

Tested Sample Types: Serum, plasma and other biological fluids

Test Principle: This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with ADMA. During the reaction, ADMA in samples or Standard competes with a fixed amount of ADMA on the solid phase supporter for sites on the Biotinylated Detection Ab specific to ADMA. Excess conjugate and unbound sample or standard are washed from the plate, and Avidin conjugated to Horseradish Peroxidase (HRP) are added to each microplate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color change is measured spectrophotometrically at a wavelength of 450 ± 2 nm. The concentration of ADMA in the samples is then determined by comparing the OD of the samples to the standard curve.

Specificity: This kit recognizes ADMA in samples. No significant cross-reactivity or interference between ADMA and analogues was observed.

Application: This ELISA kit applies to the in vitro quantitative determination of ADMA concentrations in Serum, plasma and other biological fluids.

Research Areas: Signal transduction, Cardiovascular

Storage: An unopened kit can be stored at 2-8℃ for 1 month. If the kit is not supposed to be used within 1 month, store the items separately according to the storage table in the manual once the kit is received.

ADMA (Asymmetrical Dimethylarginine) ELISA Kit DataSheet

Citation #1

Citation #2

Citation #3

Citation #4

Citation #5

Citation #6

Citation #7